- Meningitis is an inflammation of the membranes surrounding the brain and spinal cord. It is more common in neonates and infants due to their immature immune systems.
- The highest incidence is between birth and 2 years of age, especially immediately after birth and between 3-8 months. Increased exposure to infections and underlying immune problems increase risk.
- Bacteria enter the meninges through the bloodstream from sites like the ears, sinuses, skull fractures, or pneumonia. Common causes vary by age but include E. coli, Group B Strep, and H. influenzae type b.
- Symptoms depend on age but may include fever, irritability, neck stiffness, bulging fontanel
This presentation focuses on Acute Bacterial Meningitis.
Viral and fungal cause is mentioned but focus is on bacterial meningitis in Pediatrics Patient.
Feel free to correct if there is any error.
Refer to other reference books for clarity.
This presentation focuses on Acute Bacterial Meningitis.
Viral and fungal cause is mentioned but focus is on bacterial meningitis in Pediatrics Patient.
Feel free to correct if there is any error.
Refer to other reference books for clarity.
It is estimated that 1 3 rd of the world’s population is infected with Mycobacterium tuberculosis
Each year, about 9 million people develop TB, of whom about 1 5 million die
WHO has estimated that around 10 of global tuberculosis case load occurs in children( 0 14 years) of these childhood cases, 75 occur annually in 22 high burden countries that together account for 80 of the world’s estimated incident cases.
This presentation was done by Dr. Julius P. Kessy,MD. An intern Doctor at Dodoma Regional Referral Hospital (DRRH) during pediatrics unit clinical meeting and supervised by Dr. Christina K. Galabawa,MD,Mmed2, Pediatrics and Child Health, University of Dodoma (UDOM) in November, 2017.
It is estimated that 1 3 rd of the world’s population is infected with Mycobacterium tuberculosis
Each year, about 9 million people develop TB, of whom about 1 5 million die
WHO has estimated that around 10 of global tuberculosis case load occurs in children( 0 14 years) of these childhood cases, 75 occur annually in 22 high burden countries that together account for 80 of the world’s estimated incident cases.
This presentation was done by Dr. Julius P. Kessy,MD. An intern Doctor at Dodoma Regional Referral Hospital (DRRH) during pediatrics unit clinical meeting and supervised by Dr. Christina K. Galabawa,MD,Mmed2, Pediatrics and Child Health, University of Dodoma (UDOM) in November, 2017.
Infections and salivary gland disease in pediatric age: how to manage - Slide...WAidid
The slideset by Professor Susanna Esposito aims at explaining how to manage the salivary gland infections in pediatric age, from pathogenesis, to transmission, treatments and vaccination coverage, that should be urgently increased in Italy as well as in EU Countries.
Meningitis is a severe CNS pathology and early and appropriate intervention is needed to prevent adverse outcome including mortality and long term complications. This presentation focuses on the different types of meningitis and the appropriate management options
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Anti ulcer drugs and their Advance pharmacology ||
Anti-ulcer drugs are medications used to prevent and treat ulcers in the stomach and upper part of the small intestine (duodenal ulcers). These ulcers are often caused by an imbalance between stomach acid and the mucosal lining, which protects the stomach lining.
||Scope: Overview of various classes of anti-ulcer drugs, their mechanisms of action, indications, side effects, and clinical considerations.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Couples presenting to the infertility clinic- Do they really have infertility...
Meningitis in children
1. Presented by:
Dr. SONAM YADAV
Assistant professor
(Kaumarbhritya- Bal Roga)
SRV Ayu. Medical college, Lucknow
2. Meningitis is a term used to describe an
inflammation of the membranes that surround
the brain & the spinal cord.
3. • Acute bacterial meningitis is commoner in neonates and
infants than in older children.
• Their immune mechanism and phagocytic functions are
not fully matured.
4. INCIDENCE:-
The highest incidence of meningitis between birth -2 yrs
of age, with the great risk immediately following birth
and at 3-8 months of age.
Increased exposure to infections and underlying immune
system problems present at birth increase an infant’s risk
of meningitis.
5. modeS OF INFECTION:
The infection spreads hematogeneously to meninges:
Bacterial sepsis
Middle ear infection
Sinusitis
Mastoidis
Fracture of the base of skull
Head injury
Pneumonia
Empyema
Osteomylitis
Infected ventriculoperitoneal shunts
6. SIGNS & SYMPTOMS
The symptoms of
meningitis vary and
depend on the age of the
child and cause of the
infection. Common
symptoms & signs are:
Fever
Lethargy
Irritability
Bursting Headache
Photophobia
Stiff neck
Generalised hypertonia
Brudzinski sign +ve
Kernig sign+ ve
Seizures
Altered consciousness
7. Other symptoms of meningitis in Neonates/infants can
include:
Vacant stare
Projectile vomiting
Neck rigidity
Abnormal temperature(hypo/hyperthermia)
Poor feeding /weak sucking
A high pitched cry
Bulging fontanelles
Poor reflexes
8. PYOGENIC MENINGITIS
ETIOLOGY:
Meningococcal meningitis ,N. Meningitides( A,B,C
and W135) are recognized to cause epidemics.
The commonest organisms according to age group are
0-3 months E.coli, Group B streptococci, S.aureus,S.
pneumonie, Salmonella species, Listeria etc.
3 m to 2-3 yrs H. Influenzae type b, S.pneumoniae,
N.meningitides
2 yrs to15yrs
& onwards..
N . meningitides( serotype A,B,C,Y & W135)
S . pneumoniae (serotype 1,3,6,7)
H.influenzae
9. PATHOGENESIS
ENTRY OF ORGANISM THROUGH BBB
RELEASE OF CELL WALL & MEMBRANE PRODUCTS
(TEICHOIC ACIDS & ENDOTOXINS etc.)
TNF,CYTOKINES & CHEMOKINES,PAF(INFLAMMATORY MEDIATORS)
RELEASED
INFLAMED MENINGES COVERED WITH EXUDATE.
MENINGITIS
10. VIRAL MENINGITIS
Viral meningitis comprises most aseptic meningitis
syndromes. The viral agents for aseptic meningitis
include the following:
Enterovirus
Herpes virus
Paramyxovirus
Togavirus
Rhabdovirus
Retrovirus
11. Tuberculous Meningitis
complication of childhood TB & common cause of
prolonged morbidity, handicap & death.
It may occur at any age but most common between 6-
24 months of age.
C/F:
First phase symptoms( Stage of invasion)
Onset is insidious with low grade fever,loss of
appetite, disturbed sleep.
Child doesn’t play,irritable, restless or drowsy.
vomiting is frequent.
Older child may complain of headache.
Possibly preceding history of measles or another
illness with incomplete recovery.
12. Second phase symptoms( Stage of
meningitis)
Kernig & Brudzinski sign may become positive,
anterior fontanels bulges (in neonates & infants).
Twitching of muscles ,convulsions, raised temp.
Child is drowsy with neck stiffness & rigidity.
As ds progresses convulsions,neurological deficits
like monoplegia and hemiplagia may occur.
Sphincter control is usually lost.
13. Terminal phase symptoms(Stage of Coma)
Child is characteristically comatose with opisthotonus
& multiple focal paresis.
Cranial nerve palsies are present.
Pupils are dilated,often unequal with nytagmus and
squint.
Ptosis and ophthalmoplegia are frequent.
High grade fever often occurs terminally.
14. EXAMINATION
General physical- check for consciousness level
according to GCS scoring, irritability.
Vitals: Temp., HR,B.P.,R/R
Signs of Raised ICP- Bulging fontanelle, headache,
nausea, vomiting, altered level of consciousness &
papilledema.
Meningismus- check for nuchal rigidity with passive
neck flexion.
15. Brudzinski sign (hip & knee flexion with flexion of
neck).
Kernig sign( Extension of knee is limited less than
135 deg. due to spasm and pain in back of the thigh
or muscles of the back ).
Hemiparesis may present.
Rash: petechial or purpuric rash on skin or musosa
(not only in meningococcal but also pneumococcal
bactremia)
19. DIAGNOSIS (CSF EXAMINATION)
.
AGENT WBC COUNT
PER MICRO LIT.
GLUCOSE
(mg/dl)
PROTEIN
(mg/dl)
MICROBIOLOGY
NORMAL
VALUES
0-5;
Lymphocytes
50-70 15-40 Negative findings on work up
Bacterial
meningitis
100-5000;
>80% PMN
<40 >100 Specific pathogen demonstrated in
60% of Gram stain & 80% of
cultures
Viral
meningitis
10-300;
lymphocytes
Normal,
reduced
in mumps
Normal
but may
be slightly
elevated
Viral isolation , PCR assays
TBM 100-500;
lymphocytes
<40 >100 Acid fast bacillus stain, culture, PCR
Cryptococcal
meningitis
10-200;
lymphocytes
Reduced 50-200 cryptococcal antigen, culture
Aseptic
meningitis
10-300;
lymphocytes
Normal Normal,
elevated
sometimes
Negative findings on workup
20. TREATMENT
Supportive therapy:
Maintain fluid & electrolyte balance as required
Transfer whole blood, FFP or platelets as required.
Care of bowel and bladder.
Maintain temp. Control.
21. INITIAL EMPIRIC THERAPY
3rd Generation Cephalosporins such as- Ceftriaxone
or Cefotaxim.
a) Inj. Ceftriaxone100 mg/kg/day BD
b) Inj. Cefotaxim (200mg/kg/day BD) + Amikacin 15
mg/kg/day OD
A combination of Ampicillin(200/mg) and
chloramphenicol(100mg/kg/24 hrs) for 10- 14 days is
also effective as initial empiric choice
22. SYMPTOMATIC THERAPY
INCREASED ICT:
• Lumber puncture should be done very carefully in
the presence of Incresed ICT.
• Osmotic diuresis with 0.5gm/kg of mannitol as 20%
solution is administerd IV every 4-6 hour for max of
6 doses.
CONVULSIONS:
• Diazepam0.3 mg /kg ( max 5 mg) IV,followed by
Phenytoin 10-15 mg/kg as initial treatment.
• Subsequently,Phenytoin is given 5mg/kg/day IV or
oraly untill the antibiotics are continued
23. Specific Antimicrobial therapy
Probable Staphylococcal meningitis:
Vancomycin 15mg/kg/dose qid
Probable Meningococcal or Pneumococcal
Meningitis:
Penicillin 4-5 lac units/kg/day q4 hourly or
Cefotaxim 150- 200 mg/kg/day q8 hourly I V or
Ceftriaxone 100-150 mg/kg/day q12 hourly I V.
Probable H. Influenzae:
Ceftriaxone or cefotaxim IV use as sinle agent. or
Ampicillin(300 mg /kg/day IV q6 hourly + Chloramphenicol
100 mg/kg/day
24. Probable E.coli:
Ampicillin+gentamycin (200mg/kg+2.5-4 mg/kg) IV
12 hrly
Probable group B streptococci:
Penicillin 50,000 IU/kg IV 4 hrly
Probable Pseudomonas:
Inj. Ceftazidime(100 mg/kg/day BD)+ Inj Amikacin
25. Antibiotics IV:
Duration; 1-3 wks depending on age & type of
organisms.
Anti –virals:
Acyclovir
Ganciclovir
Anti-fungals:
Amphotericin B
Fluconazole
26. Steroid Therapy:
• Dexamethasone in dose of 0.15 mg/kg IV 6 hourly for
2-4 days is recommended.
• The first dose of corticosteroid should precede
antibiotic use by at least 15 minutes.
• This helps to reduce the incidence of residual
neurological complications,such as sensorineural
deafness, possibly internal hydrocephalus & behavioral
disturbances.
• This is specially useful in H.influezae meningitis
• There is no role of Dexamethasone in Neonatal
meningitis.
27. TREATMENT OF TBM
12 months regimen of ATT-2HRZE + 10 HR
Steroid – 1-2 mg/kg/day in divided BD doses for 8-12
wks
Full dose given for 8 wks & then tapered in next 4
wks.
Supportive therapy.